Logo
Login
$MREO
$0.29 +$0.02 (6.07%) Close

Company Executives

$MREO Management Team

Mr. Michael Wyzga

Non-Executive Independent Chairman of the Board

Age 70
Compensation $246.6K GBP
Sex Male

Dr. Denise Scots-Knight

Chief Executive Officer

Director

Age 65
Compensation $3.163M GBP
Sex Female

Ms. Christine Fox

Chief Financial Officer

Age 44
Compensation $1.262M GBP
Sex Female

Dr. John Lewicki

Chief Scientific Officer

Age 73
Compensation $479.2K GBP
Sex Male

Mr. Charles Sermon

General Counsel and Business Development

Company Secretary

Age 55
Compensation $1.306M GBP
Sex Male

Ms. Alexandra Hughes-Wilson

Chief Patient Access and Commercial Planning

Age 53
Compensation $359.3K GBP
Sex Female

Board of Directors

From the proxy statement filed Apr 9, 2026
Directors
10
serving now
Independent
Not stated
the proxy does not say
Average tenure
7.0 years
from year joined
CEO also chairs the board
Not stated
no chair stated
Director Age On board Independent Committees Other public boards 2025 pay Source
Justin Roberts
Not stated Not stated Not stated
Remuneration Committee
None stated Not stated
Daniel Shames
Not stated Not stated Not stated None stated None stated Not stated
Marc Yoskowitz
Not stated Not stated Not stated None stated None stated $181,167
Denise Scots-Knight
CEO
 Not stated Not stated Not stated None stated Elanco Animal Health Incorporated Paid as CEO
Michael Wyzga
Not stated 2019
7 years
 Not stated
Nomination and Corporate Governance Committee · Chair
GenSight Biologics S.A. $234,154
Jeremy Bender
Not stated Not stated Not stated None stated None stated Not stated
Anders Ekblom
Not stated Not stated Not stated None stated Xspray Pharma AB Not stated
Pierre Jacquet
Not stated Not stated Not stated None stated Neurvati Not stated
Deepika Pakianathan
Not stated Not stated Not stated None stated Theravance Biopharma, Inc., Karyopharm Therapeutics, Inc. Not stated
Annalisa Jenkins Leaving at the meeting
Not stated Not stated Not stated None stated Compass Pathways plc, Skye Bioscience, Inc. Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 9, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans